Perforomist and Simvastatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Perforomist (formoterol fumarate) and Simvastatin (simvastatin). Common drug interactions include international normalised ratio increased among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Perforomist and Simvastatin. It is created by eHealthMe based on reports of 75 people who take the same drugs from the FDA, and is updated regularly.

What is Perforomist?

Perforomist has active ingredients of formoterol fumarate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 1,431 Perforomist users. Check the latest studies of Perforomist.

What is Simvastatin?

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,969 Simvastatin users. Check the latest studies of Simvastatin.



On Jul, 16, 2026

75 people who take Perforomist and Simvastatin together, and have interactions are studied.

Perforomist and Simvastatin drug interactions.

What are the common drug interactions of Perforomist and Simvastatin, by gender? *:

female:

  1. International normalised ratio increased
  2. Mouth haemorrhage (bleeding from mouth)
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Neuropathy peripheral (surface nerve damage)
  5. Productive cough
  6. Pulmonary oedema (fluid accumulation in the lungs)
  7. Asthma
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Cardiac disorder
  3. Death
  4. Dehydration (dryness resulting from the removal of water)
  5. Dementia (madness)
  6. Drug effect decreased
  7. Drug hypersensitivity
  8. Fall
  9. Fluid retention (an abnormal accumulation of fluid in the blood)
  10. General physical health deterioration (weak health status)

What are the common drug interactions of Perforomist and Simvastatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Abdominal pain upper
  3. Drug effect decreased
  4. Drug ineffective
  5. Influenza
  6. Insomnia (sleeplessness)
  7. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  8. Somnolence (a state of near-sleep, a strong desire for sleep)

50-59:

  1. Drug ineffective
  2. Renal failure (kidney dysfunction)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Anticonvulsant drug level increased
  5. Cardiac disorder
  6. Gait disturbance
  7. Lung disorder (lung disease)
  8. Anticonvulsant drug level decreased
  9. Balance disorder
  10. Chronic kidney disease

60+:

  1. Pain in extremity
  2. Dyspnoea (difficult or laboured respiration)
  3. Respiratory distress (difficulty in breathing)
  4. Fatigue (feeling of tiredness)
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Haemorrhage (bleeding)
  7. Aphasia (damage to the parts of the brain that control language)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Cardiac failure congestive
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the existing conditions these people have? *

  1. Neuropathy Peripheral (surface nerve damage): 15 people, 20.00%
  2. Neuralgia (pain in one or more nerves): 13 people, 17.33%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 14.67%
  4. Weight Increased: 9 people, 12.00%
  5. Gout (uric acid crystals building up in the body): 9 people, 12.00%
  6. High Blood Pressure: 9 people, 12.00%
  7. Dyspnea (difficult or laboured breathing): 8 people, 10.67%
  8. Immunodeficiency Common Variable: 7 people, 9.33%
  9. Stress And Anxiety: 7 people, 9.33%
  10. Pain: 7 people, 9.33%

* Approximation only. Some reports may have incomplete information.

Do you take Perforomist and Simvastatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Perforomist and Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Perforomist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Perforomist and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simvastatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on formoterol fumarate and simvastatin (the active ingredients of Perforomist and Simvastatin, respectively), and Perforomist and Simvastatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: